Depo-Provera or Depo-SubQ Provera 104®

Attention: Depo-Provera or Depo-SubQ Provera 104® injections at least twice a week show an increased risk of cranial and spinal meningiomas.

If you or a loved one developed meningiomas after receiving Depo-Provera or Depo-SubQ Provera injections and are in need of representation in filing a Depo-Provera lawsuit, call us James Morris Law Firm, PC  at 747-283-1144 or email us at jmorris@jamlawyers.com Our firm provides individual representation on a contingency basis. If we don’t win, you don’t pay.

Depo-Provera is a birth control injection. Depo-SubQ Provera 104 injections are used for birth control and to manage endometriosis-associated pain. Both contain progestin to suppress ovulation, and act as a contraceptive by keeping a woman’s ovaries from releasing an egg. Depo-Provera shots are given every 13 weeks via an injection into muscle in the buttock or upper arm, while Depo-SubQ Provera is injected just beneath the skin in the thigh or abdomen every 12 to 14 weeks.

The FDA approved Depo-Provera for use in the United States in 1992, but it has been used around the world for almost 60 years. Somewhere between one million and two million women in the United States receive Depo-Provera injections each year, and about 20 percent of all women in America have used Depo-Provera in their lifetime.

Studies have indicated that use of high-dose progestogen medications, such as Depo-Provera and Depo-SubQ Provera, are linked to an increased risk of a woman developing cranial and spinal meningioma. In fact, the risk for users of Depo-Provera was the highest of the medications studied: a 5.55-fold increased risk.